Clinical Trial Update: A Safety and Tolerability Clinical Trial of PST-611 in Dry Age-related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing safety and tolerability of PST-611 in dry age-related macular degeneration; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Age-related Macular Degeneration

Drugs mentioned

• PST-611

Snippet

Sponsor: Eyevensys | Conditions: Dry Age Related Macular Degeneration | Phase 1 | Status: NOT_YET_RECRUITING